Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors

Ikena Oncology (Nasdaq: IKNA, “Ikena”), a targeted oncology company navigating new territory in patient-directed cancer treatment, today announced the appointment of Richard Wooster, Ph.D., to its Board of Directors...
Login to comment.